Episode Details
Back to Episodes
Moderna's good news goes bad
Published 1 week, 5 days ago
Description
Moderna's (MRNA) cancer vaccine clears a hurdle, but the stock hits a wall. (00:13) Tower stocks (CCI) (AMT) soar as investors size up a major opportunity. (01:29) Kohl's (KSS) gets a rare buy rating. (02:25)
Episode transcripts seekingalpha.com/wsb.
Show links:
Biggest stock movers Friday: SKHY, MRNA, DECK, and more
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Episode transcripts seekingalpha.com/wsb.
Show links:
Biggest stock movers Friday: SKHY, MRNA, DECK, and more
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.